Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.

[1]  C. Wang,et al.  Association of C-peptide with diabetic vascular complications in type 2 diabetes. , 2020, Diabetes & metabolism.

[2]  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[3]  J. McGill,et al.  Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial. , 2017, Annals of internal medicine.

[4]  C. Sainsbury,et al.  A Practical Review of C-Peptide Testing in Diabetes , 2017, Diabetes Therapy.

[5]  Gerry Rayman,et al.  Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial , 2016, Diabetes Therapy.

[6]  L. Dimeglio,et al.  Elevations in the Fasting Serum Proinsulin–to–C-Peptide Ratio Precede the Onset of Type 1 Diabetes , 2016, Diabetes Care.

[7]  J. Tuomilehto,et al.  Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial) , 2015, BMJ : British Medical Journal.

[8]  J. Tuomilehto,et al.  Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial). , 2015, Primary care diabetes.

[9]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.

[10]  T. Mavrakanas,et al.  C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome. , 2009, Presse medicale.

[11]  M. Balci,et al.  Relationship between C peptide and chronic complications in type-2 diabetes mellitus. , 2005, Journal of the National Medical Association.

[12]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.